N-(2,3-Dimethylphenyl)-2-((4-(2,4-dimethylphenyl)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl)thio)acetamide

Catalog No. :
ACIRXV238
CAS No. :
539808-94-1
Molecular Formula :
C27H28N4O2S
Molecular Weight :
472.61

IUPAC Name:N-(2,3-dimethylphenyl)-2-((4-(2,4-dimethylphenyl)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl)thio)acetamide

N-(2,3-Dimethylphenyl)-2-((4-(2,4-dimethylphenyl)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,3-Dimethylphenyl)-2-((4-(2,4-dimethylphenyl)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl)thio)acetamide
IUPAC NameN-(2,3-dimethylphenyl)-2-((4-(2,4-dimethylphenyl)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl)thio)acetamide
MDL No.MFCD03460712
Molecular FormulaC27H28N4O2S
Molecular Weight472.61
SMILESO=C(NC1=CC=CC(C)=C1C)CSC2=NN=C(COC3=CC=CC=C3)N2C4=CC=C(C)C=C4C
InChI KeyVCSJSHPNIVVIAZ-UHFFFAOYSA-N
SynonymSALOR-INT L444251-1EA;N-(2,3-DIMETHYLPHENYL)-2-([4-(2,4-DIMETHYLPHENYL)-5-(PHENOXYMETHYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)ACETAMIDE;Acetamide, N-(2,3-dimethylphenyl)-2-[[4-(2,4-dimethylphenyl)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl]thio]-
CAS No.539808-94-1

Synthetic Route by SureRoute

1. ACIRXV238 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRXV238 route product structure diagram
    ACIRXV238539808-94-1
Inquiry

2. ACIRXV238 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWBRP360 route compound structure diagram
    ACWBRP3602564-07-0 In Stock
  4. Then
  5. ACIRXV238 route product structure diagram
    ACIRXV238539808-94-1
Inquiry

Comments (0)